When to Order Imaging for Cerebrovascular Disease-Child: ACR Appropriateness Decoded
When to Order Imaging for Cerebrovascular Disease-Child: ACR Appropriateness Decoded
It’s late in the evening when a 7-year-old presents to the emergency department with acute-onset right-sided weakness and aphasia. The clinical suspicion for stroke is high, but the next step is critical. Do you order a non-contrast CT to quickly rule out hemorrhage, or go directly to an MRI/MRA for a more definitive diagnosis of ischemia, knowing it will take longer and may require sedation? This scenario highlights a common and high-stakes decision point in pediatric medicine. Choosing the right initial imaging study for suspected cerebrovascular disease in a child involves balancing diagnostic yield, speed, availability, and the principle of minimizing radiation exposure. This guide breaks down the American College of Radiology (ACR) Appropriateness Criteria to help you navigate these complex decisions with evidence-based recommendations.
What Does ACR Cerebrovascular Disease-Child Cover?
The ACR Appropriateness Criteria for Cerebrovascular Disease-Child provide guidance for imaging children (typically older than 6 months) presenting with signs and symptoms of acute stroke or other cerebrovascular events. The guidelines are structured around specific clinical variants that cover a range of potential underlying causes.
This topic specifically addresses:
- Initial imaging for acute ischemic stroke, both for patients who are and are not candidates for emergent intervention.
- Evaluation of suspected or known arteriopathies like moyamoya disease, cervicocranial arterial dissection, and central nervous system (CNS) vasculitis.
- Workup for nontraumatic intracranial hemorrhage, including intraparenchymal and subarachnoid hemorrhage.
- Assessment of suspected high-flow and low-flow vascular anomalies.
- Diagnosis of suspected cortical vein or dural venous sinus thrombosis.
- Initial imaging for acute stroke in children with sickle cell disease.
These criteria do not cover routine screening, post-treatment follow-up, or imaging for neonatal stroke (birth to 28 days), which has distinct etiologies and imaging considerations. The focus is on the initial diagnostic workup in the acute or subacute setting.
What Imaging Should I Order for Cerebrovascular Disease-Child? Recommendations by Clinical Scenario
The optimal imaging strategy for a child with suspected cerebrovascular disease depends entirely on the specific clinical presentation and suspected etiology. The ACR guidelines prioritize non-ionizing radiation modalities like MRI and MRA whenever feasible, reflecting the importance of the As Low As Reasonably Achievable (ALARA) principle in pediatric imaging.
Acute Ischemic Stroke
For a child older than 6 months with an emergent presentation of acute nonsickle–cell related stroke (a candidate for intervention), the ACR rates MRA head without IV contrast, MRI head without IV contrast, and CT head without IV contrast as Usually appropriate. The choice between them often depends on institutional resources and patient stability. CT is faster and excellent for ruling out hemorrhage, while MRI/MRA provides superior detail for identifying early ischemic changes and vascular occlusion.
In cases where the child is not a candidate for emergent intervention, the recommendations are identical, with non-contrast MRI, MRA, and CT all rated as Usually appropriate. This provides flexibility based on local availability and the specific clinical question.
Arteriopathies and Vasculitis
When the presentation suggests an underlying arteriopathy, such as moyamoya disease, MRA head without IV contrast and MRI head without IV contrast are Usually appropriate. These studies can reveal the characteristic stenosis and collateral vessel formation without radiation or contrast.
For a child with known or suspected cervicocranial arterial dissection, the imaging field must be expanded. MRA head and neck without IV contrast, MRI head and neck without IV contrast, and CTA head and neck with IV contrast are all Usually appropriate to identify intramural hematoma, vessel stenosis, or occlusion.
In suspected central nervous system vasculitis, multiple modalities are considered Usually appropriate, including MRA head without IV contrast, MRI head without and with IV contrast, MRI head without IV contrast, and CTA head with IV contrast. Contrast-enhanced MRI can be particularly valuable for assessing inflammatory vessel wall changes and parenchymal enhancement.
Hemorrhagic Stroke and Vascular Malformations
Following the discovery of a nontraumatic intraparenchymal hemorrhage of unknown etiology, the workup focuses on identifying an underlying vascular lesion. Arteriography (DSA), MRA head without IV contrast, MRI head without and with IV contrast, and CTA head with IV contrast are all Usually appropriate next steps.
Similarly, for nontraumatic subarachnoid hemorrhage (SAH), the primary goal is to find a source, most commonly an aneurysm. Arteriography remains a gold standard, but MRA head without IV contrast and CTA head with IV contrast are also Usually appropriate non-invasive alternatives.
For suspected high-flow vascular anomalies, non-contrast MRA and MRI, non-contrast CT, and CTA with contrast are all Usually appropriate. For suspected low-flow vascular anomalies, MRI head without IV contrast and CT head without IV contrast are the most appropriate initial studies.
Venous Thrombosis and Sickle Cell Disease
If there is concern for cortical vein or dural venous sinus thrombosis, direct visualization of the venous system is key. A wide range of studies are Usually appropriate, including MRI head without and with IV contrast, MRV head with or without IV contrast, CT head without IV contrast, and CTV head with IV contrast. Non-contrast CT may show a dense clot, but contrast-enhanced studies provide a definitive diagnosis.
Finally, for a child with sickle cell disease presenting with a new focal neurologic deficit, the initial imaging is focused on identifying ischemia or hemorrhage. MRA head without IV contrast, MRI head without IV contrast, and CT head without IV contrast are all Usually appropriate.
ACR Imaging Recommendations Table
| Clinical Scenario | Top Procedure | ACR Rating | Adult RRL | Pediatric RRL |
|---|---|---|---|---|
| Child age older than 6 months. Emergent imaging for clinical presentation suggestive of acute nonsickle–cell related stroke. New focal fixed or worsening neurologic defect lasting less than 24 hours from last seen normal state. No contraindications to emergent intervention. Initial imaging. | MRI head without IV contrast | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
| Child. Clinical presentation suggestive of acute stroke, not a candidate for emergent intervention. Initial imaging. | MRA head without IV contrast | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
| Child. Clinical presentation suggestive of acute stroke, known or suspected arteriopathy, or moyamoya. Not a candidate for emergent treatment. Initial imaging. | MRA head without IV contrast | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
| Child. Known or suspected cervicocranial arterial dissection based on clinical or imaging findings. Next imaging study. | MRA head and neck without IV contrast | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
| Child. Clinical presentation suggestive of acute stroke, known or suspected central nervous system vasculitis. Initial imaging. | MRI head without and with IV contrast | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
| Child. Nontraumatic intraparenchymal hemorrhage (hematoma) found on CT or MRI. Unknown etiology. Next imaging study. | Arteriography cervicocerebral | Usually appropriate | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
| Child. Nontraumatic subarachnoid hemorrhage (SAH) detected by noncontrast CT. Next imaging study. | Arteriography cervicocerebral | Usually appropriate | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
| Child. Clinical presentation suggestive of acute stroke, known or suspected high-flow vascular anomaly. Initial imaging. | MRA head without IV contrast | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
| Child. Clinical presentation suggestive of acute stroke, known or suspected low-flow vascular anomaly. Initial imaging. | MRI head without IV contrast | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
| Child. Clinical presentation suggestive of acute stroke, known or suspected cortical vein or dural venous sinus thrombosis. Initial imaging. | MRV head without IV contrast | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
| Child. Clinical presentation suggestive of acute stroke, sickle cell disease. New focal fixed or worsening neurologic defect. Initial imaging. | MRI head without IV contrast | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
Adult vs. Pediatric Cerebrovascular Disease-Child Imaging: Radiation Dose Tradeoffs
A central theme in pediatric imaging is minimizing lifetime radiation exposure. Children are more radiosensitive than adults, and their longer life expectancy provides more time for potential stochastic effects of radiation to manifest. The ACR criteria for pediatric cerebrovascular disease reflect this by frequently rating non-ionizing modalities like MRI and MRA as “Usually appropriate.”
The Relative Radiation Level (RRL) designations often include a specific pediatric value, marked with “[ped],” which is typically lower than the adult equivalent. For example, a non-contrast head CT has a pediatric RRL of ☢ ☢ ☢ (0.3-3 mSv), while the adult RRL is also ☢ ☢ ☢ but corresponds to a higher dose range (1-10 mSv). This is achieved through size-specific CT protocols that adjust scanner parameters to the child’s smaller body habitus.
While CT and CTA are indispensable for their speed and ability to rapidly detect hemorrhage, the decision to use them must be weighed against the availability and feasibility of radiation-free alternatives. For many non-emergent scenarios, or when the primary question is identifying ischemia or vascular anatomy, MRI/MRA is the preferred first-line modality, provided the child is stable enough for the longer scan time and can cooperate or be safely sedated.
Imaging Protocol Details for Cerebrovascular Disease-Child
Once you’ve decided on the right study, the specific imaging protocol is essential for diagnostic quality. Technique, sequence selection, and contrast timing can significantly impact the exam’s utility. Our protocol guides provide detailed, practical information for the key studies recommended in these ACR criteria.
Tools to Help You Order the Right Study
Navigating imaging guidelines can be complex, especially under clinical pressure. GigHz offers several resources designed to support evidence-based decision-making at the point of care.
For scenarios beyond pediatric cerebrovascular disease, the ACR Appropriateness Criteria Lookup tool provides a searchable interface to the full library of ACR guidelines, helping you find the right study for thousands of clinical presentations.
To ensure exams are performed correctly, the Imaging Protocol Library offers detailed, step-by-step protocols for a comprehensive range of CT, MRI, and other imaging procedures, standardizing quality across your institution.
When discussing radiation with families or tracking a patient’s cumulative exposure, the Radiation Dose Calculator is a valuable tool for estimating effective dose from various imaging studies and communicating these concepts in understandable terms.
Frequently Asked Questions (FAQ)
Why is non-contrast MRI/MRA often preferred over CT/CTA for initial evaluation of pediatric stroke?
MRI and MRA are often preferred because they do not use ionizing radiation, which is a key consideration in children (ALARA principle). Furthermore, MRI, particularly with diffusion-weighted imaging (DWI), is more sensitive than CT for detecting acute ischemic stroke in its earliest stages. MRA provides excellent visualization of the intracranial and cervical vasculature to identify occlusions or stenosis, all without the need for iodinated contrast.
When is CT the better first choice for a child with suspected stroke?
Non-contrast head CT is the best initial choice in several situations. Its primary advantage is speed and accessibility; it can be completed in minutes, making it ideal for unstable patients. Its main role is to rapidly and reliably rule out intracranial hemorrhage, which is a critical step before any potential thrombolytic or endovascular therapy can be considered. If MRI is not immediately available or if the child cannot tolerate a long scan, CT is the go-to initial study.
What is the role of conventional angiography (arteriography) in pediatric stroke?
Conventional digital subtraction angiography (DSA), or arteriography, is an invasive procedure that is typically reserved for problem-solving or for therapeutic intervention. It is considered a gold standard for vessel imaging and may be used when non-invasive studies like MRA or CTA are inconclusive. It is particularly valuable for diagnosing and characterizing complex vascular malformations, small vessel vasculitis, or aneurysms. It is also the primary modality for endovascular treatments like mechanical thrombectomy or aneurysm coiling.
Why are some contrast-enhanced studies rated “Usually not appropriate” for initial imaging?
A “Usually not appropriate” rating for a contrast-enhanced study in an initial setting often means that the necessary diagnostic information can be obtained from a non-contrast study. This approach avoids the potential risks associated with IV contrast agents (e.g., gadolinium retention or allergic reactions to iodinated contrast) unless there is a specific indication. For example, in an initial stroke workup, a non-contrast MRI can confirm ischemia and a non-contrast MRA can show a vessel occlusion. Contrast is typically added later if specific questions arise, such as suspicion for vasculitis, venous thrombosis, or tumor.
What does the “(Disagreement)” tag next to an ACR rating signify?
The “(Disagreement)” tag indicates that while the final rating reflects the median score of the expert panel, there was a notable lack of consensus among the panel members. Specifically, at least four out of the 15-17 voting members rated the procedure outside of the 3-point range of the final median rating. This highlights areas where clinical practice may vary and where the evidence may be less definitive, suggesting that clinical judgment and local expertise are particularly important in these scenarios.
Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 12, 2026
